Malignant Thymus Neoplasm — Trials

Malignant Thymus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 80
Recruiting: 43
Ph III recruiting: 1
Growth YoY: —
Industry share: 23%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00965250	Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy	completed	Phase 2	49	National Cancer Institute (NCI)NIH	1	Dec 23, 2016	clinicaltrials
NCT01135849	B-Receptor Signaling in Cardiomyopathy	completed	—	99	Daniel BernsteinOTHER	1	Nov 17, 2015	clinicaltrials